CME to retire Nex, revives EBS as sub-brand

The deal between the two firms will go ahead after full regulatory approval in all jurisdictions

Hand shake
CME-Nex deal: birth of a giant in OTC and exchange FX, as well as US treasuries and commodities

CME Group has completed the acquisition of Nex, following regulatory approval for the deal to go ahead. The group announced it will retire the Nex brand and bring back EBS as a sub-brand for CME. 

The UK’s Competition Authority approved the deal on October 31, and courts sanctioned the arrangement on November 1.

“CME Group will retire the Nex name and brand, but will continue to operate its individual markets and optimisation businesses as sub-brands, including BrokerTec, EBS, Traiana and

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact customer services -, or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to FX Markets? View our subscription options

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: